Hypertension: do we need to consider the biological clock in drug dosing?

References

• Cannon CP, McCabe CH, Stone PH et al. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB). Am. J. Cardiol.79, 253–258 (1997).
   PubMed Web of Science ®Google Scholar
• Glasser SP, Neutel JM, Gana TJ, Albert KS. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension. Am. J. Hypertens.16, 51–58 (2003).
   PubMed Web of Science ®Google Scholar
• Sista S, Chi-Keung Lai J, Eradiri O, Albert K. Pharmacokinetics of a novel diltiazem HCL extended-release tablet formulation for evening administration. J. Clin. Pharmacol.43, 1149–1157 (2003).
   PubMed Web of Science ®Google Scholar
• Sica D, Frishman WH, Manowitz N. Pharmacokinetics of propranolol after single and multiple dosing with sustained released propranolol or propranolol CR (Innopran XL™), a new chronotherapeutic formulation. Heart Disease5, 176–181 (2003).
   PubMedGoogle Scholar
• Neutel JM, Rotemberg K. Comparison of a chronotherapeutically administered β blocker vs. a traditionally administered β blocker in patients with hypertension. J. Clin. Hypertens.7, 395–400 (2005).
   PubMedGoogle Scholar
• Prisant LM, Devane JG, Butler J. A steady state evaluation of the bioavailability of chronotherapeutic oral drug absorption system verapamil PM after nighttime dosing versus immediate-acting verapamil dosed every eight hours. Am. J. Ther.7, 345–251 (2000).
   PubMedGoogle Scholar
• Prisant LM, Weber M, Black HR. The role of circadian rhythm in cardiovascular function-efficacy of a chronotherapeutic approach to controlling hypertension with Veralan PM (verapamil HCL). Today’s Therapeutic Trends21, 201–213 (2003).
   Google Scholar
• Smith DHG, Neutel JM, Weber MA. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. Am. J. Hypertens.14, 14–19 (2001).
   PubMed Web of Science ®Google Scholar
• White W, Mehrotra D, Black HR, Kakouhi DT. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). Am. J. Cardiol.80, 469–474 (1997).
   PubMed Web of Science ®Google Scholar
• White WB, Anders RJ, MacInyre JM, Black HR, Sica DA. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Am. J. Cardiol.76, 375–380 (1995).
   PubMed Web of Science ®Google Scholar
• White WB, Black HR, Weber M, Elliott WJ, Bryzinski B, Fakouhi TD. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and heart rate-blood pressure product. Am. J. Cardiol.81, 424–431 (1998).
   PubMed Web of Science ®Google Scholar
• Cutler NR, Anders RJ, Sanford S et al. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris. Am. J. Cardiol.75, 1102–1106 (1995).
   PubMed Web of Science ®Google Scholar
• Gupta SK, Yih BM, Atkinson L, Longstreth J. The effect of food, time of dosing and body composition on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil. J. Clin. Pharmacol.35, 1083–1093 (1995).
   PubMed Web of Science ®Google Scholar
• Mengden T, Binswanger B, Gruene S, Spühler T, Weisser B, Vetter W. Dynamics of drug compliance and 24-hour blood pressure control of once daily morning vs evening amlodipine. J. Hypertens.10(Suppl. 4), S136(P103) (1992).
   Google Scholar
• Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press. Monit.3, 17–25 (1998).
   PubMedGoogle Scholar
• Fogari R, Malacco E, Tettamanti F, Gnemmi AE, Milani M. Evening vs morning isradipine sustained release in essential hypertension – a double-blind study with 24-h ambulatory monitoring. Br. J. Clin. Pharmacol.35, 51–54 (1993).
   PubMed Web of Science ®Google Scholar
• van Montfrans GA, Schelling A, Buurke EJ, Schut N, Houben JJ. Dosing time of lacidipine and the circadian blood pressure curve: the MOTIME study. J. Hypertens.16(Suppl. 9), S15–S19 (1998).
   PubMed Web of Science ®Google Scholar
• Greminger P, Suter PM, Holm D, Kobelt R, Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin. Investig.72, 864–869 (1994).
   PubMedGoogle Scholar
• White WB, Mansoor GA, Pickering TG et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am. J. Hypertens.12, 806–814 (1999).
   PubMed Web of Science ®Google Scholar
• Meilhac B, Mallion JM, Carre A et al. Antihypertensive effect and tolerance of nitrendipine administered either in the morning or in the evening of office and ambulatory blood pressure. Therapie47, 205–210 (1992).
   PubMed Web of Science ®Google Scholar
• Umeda T, Naomi S, Iwaoka T et al. Timing for administration of an antihypertensive drug in the treatment of essential hypertension. Hypertension23(Suppl. 1), I211–I214 (1994).
   Google Scholar
• Lemmer B, Luders S, Nold G, Schrader J, Manfredini R, Portaluppi F. Normalisation of non-dipping blood pressure profile by amlodipine after single morning or evening dosing. Am. J. Hypertens.15, 109A (2002).
   Google Scholar
• Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension of chronic renal failure. Am. J. Hypertens.8, 719–726 (1995).
   PubMed Web of Science ®Google Scholar
• Lemmer B, Nold G, Behne S, Kaiser R. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol. Int.8, 485–494 (1991).
   PubMed Web of Science ®Google Scholar
• Lemmer B. The importance of circadian rhythms on drug response in hypertension and coronary heart disease – from mice and man. Pharmacol. Ther.111, 629–651 (2006).
   PubMed Web of Science ®Google Scholar
• Palatini P, Mos L, Motolese M et al. Effect of evening versus morning benazepril on 24-hour blood pressure – a comparative study with continuous intraarterial monitoring. Int. J. Clin. Pharmacol. Ther. Toxicol.31, 295–300 (1993).
   PubMed Web of Science ®Google Scholar
• Witte K, Weisser K, Neubeck M et al. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin. Pharmacol. Ther.54, 177–186 (1993).
   PubMed Web of Science ®Google Scholar
• Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J. Hypertens.15, 205–211 (1997).
   PubMed Web of Science ®Google Scholar
• Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin. Pharmacol. Ther.52, 378–383 (1992).
   PubMed Web of Science ®Google Scholar
• Myburgh DP, Verho M, Botes JH, Erasmus TP, Luus HG. 24-hour blood pressure control with ramipril: comparison of once-daily morning and evening administration. Curr. Ther. Res. Clin. Exp.56, 1298–1306 (1995).
   Web of Science ®Google Scholar
• Koroda T, Kario K, Hoshide S et al. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens. Res.27, 15–20 (2004).
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension42, 283–290 (2003).
   PubMed Web of Science ®Google Scholar